Cancer News and Research

Latest Cancer News and Research

Two intrauterine contraceptive systems safe and effective in preventing pregnancies

In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

5 Dec 2013

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

A Cleveland Clinic-led study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.

5 Dec 2013

Training advised to plug lung cancer care gaps

Guideline-consistent care for patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases varies by region and physician characteristics, say researchers.

5 Dec 2013

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).

5 Dec 2013

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Presence Health, the largest Catholic health system based in Illinois, significantly increased screening rates for colorectal cancer by utilizing automated, interactive voice response calls, according to research being presented on Dec. 10 at the Institute for Healthcare Improvement's 25th Annual National Forum on Quality Improvement in Health Care.

5 Dec 2013

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.

5 Dec 2013

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.

5 Dec 2013

First Edition: December 5, 2013

Today's headlines include reports about how President Barack Obama is trying to connect with young adults and urge them to sign up for health coverage.

5 Dec 2013

"Virtual T cell" predicts how human immune system reacts to foreign substances

A platform that simulates how the body defends itself: The T cells of the immune system decide whether to trigger an immune response against foreign substances.

5 Dec 2013

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Biothera researchers have broadened their understanding of a biomarker that may enable doctors to predict which cancer patients will best respond to Imprime PGG®, the company's immunotherapy in Phase 3 drug development for colorectal cancer.

5 Dec 2013

All China Biotech Conference & Exhibition to be held in Nanjing on May, 2014

Jointly organized by Nanjing Pushlong Business Management Co., Ltd. and more than 10 national associations, the All China Biotech Conference & Exhibition (Biotech China) will be held in Nanjing on May 14-16, 2014, providing a platform for business and academic exchanges.

5 Dec 2013

SingHealth, Duke-NUS Graduate Medical School join global network to boost healthcare research

SingHealth and Duke-NUS Graduate Medical School, which form Singapore's largest academic healthcare cluster, are joining a new global research network to accelerate the discovery of treatments and cures. They will be signing a memorandum of understanding with the Eureka Institute for Translational Medicine today.

5 Dec 2013

Findings suggest new approach for treating inflammatory bone diseases and skeletal metastases

The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.

5 Dec 2013

Capsule endoscopy could identify presence of "occult" blood at very low levels

A tiny capsule that can carry out a chemical analysis of the contents of one's stomach could identify the presence of so-called "occult" blood at very low levels. The data is automatically broadcast to an external monitoring device for detection of early stage stomach cancer by one's physician. Details of the invention and initial trials are described in a forthcoming issue of the International Journal of Biomedical Engineering and Technology.

5 Dec 2013

Palomar Health becomes the newest member of Mayo Clinic Care Network

Mayo Clinic today announced Palomar Health, the largest public health care district in California, as the newest member of the Mayo Clinic Care Network. This agreement formalizes a unique relationship between the two institutions that will allow physicians and specialists to collaborate and provide Palomar Health patients with access to Mayo Clinic's experts and medical resources.

5 Dec 2013

Evidence reveals lack of public acceptance toward breast-feeding may influence hesitation

African-American mothers breast-feed their children at lower rates than Caucasian, Latina and Asian mothers. This difference often has been attributed to socio-demographic factors such as age, income, education and personal experience with breast-feeding.

5 Dec 2013

IDSA released new guideline for vaccination of immunocompromised hosts

A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised immune systems are especially vulnerable to illness and should receive the flu shot and other vaccinations.

5 Dec 2013

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells

A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.

5 Dec 2013

Archimedes Model simulation suggests genetic screening for breast cancer risk can reduce deaths

Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease.

5 Dec 2013

New method for counting tumor-fighting cells to predict ovarian cancer

One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it - a sign of the body's immune response to the cancer. However, quantifying these armies of immune cells has been difficult - until now.

5 Dec 2013

Cancer News and Research

Latest Cancer News and Research

Two intrauterine contraceptive systems safe and effective in preventing pregnancies

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

Training advised to plug lung cancer care gaps

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

First Edition: December 5, 2013

"Virtual T cell" predicts how human immune system reacts to foreign substances

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

All China Biotech Conference & Exhibition to be held in Nanjing on May, 2014

SingHealth, Duke-NUS Graduate Medical School join global network to boost healthcare research

Findings suggest new approach for treating inflammatory bone diseases and skeletal metastases

Capsule endoscopy could identify presence of "occult" blood at very low levels

Palomar Health becomes the newest member of Mayo Clinic Care Network

Evidence reveals lack of public acceptance toward breast-feeding may influence hesitation

IDSA released new guideline for vaccination of immunocompromised hosts

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells

Archimedes Model simulation suggests genetic screening for breast cancer risk can reduce deaths

New method for counting tumor-fighting cells to predict ovarian cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in